rimcure 150 mg/75 mg/400 mg filmdragerad tablett
sandoz a/s - isoniazid; pyrazinamid; rifampicin - filmdragerad tablett - 150 mg/75 mg/400 mg - isoniazid 75 mg aktiv substans; natriumlaurilsulfat hjälpämne; rifampicin 150 mg aktiv substans; pyrazinamid 400 mg aktiv substans - pyrazinamid och isoniazid
lepitil vet 60 mg tablett
chanelle pharmaceuticals manufacturing ltd - fenobarbital - tablett - 60 mg - fenobarbital 60 mg aktiv substans; laktosmonohydrat hjälpämne - fenobarbital - hund
metotrexat astron 50 mg/ml injektionsvätska, lösning i förfylld spruta
astron research ltd - metotrexat - injektionsvätska, lösning i förfylld spruta - 50 mg/ml - metotrexat 50 mg aktiv substans
colchimex 500 mikrogram tablett
rph pharmaceuticals ab - kolkicin - tablett - 500 mikrogram - laktosmonohydrat hjälpämne; kolkicin 500 mikrog aktiv substans
fluticasone elpen 250 mikrogram/dos inhalationspulver, avdelad dos
elpen pharmaceutical co. inc - flutikasonpropionat - inhalationspulver, avdelad dos - 250 mikrogram/dos - flutikasonpropionat 250 mikrog aktiv substans; laktosmonohydrat hjälpämne
fluticasone elpen 500 mikrogram/dos inhalationspulver, avdelad dos
elpen pharmaceutical co. inc - flutikasonpropionat - inhalationspulver, avdelad dos - 500 mikrogram/dos - flutikasonpropionat 500 mikrog aktiv substans; laktosmonohydrat hjälpämne
axura
merz pharmaceuticals gmbh - memantinhydroklorid - alzheimers sjukdom - andra anti-demensmedel - behandling av patienter med måttlig till svår alzheimers sjukdom.
skyrizi
abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - immunsuppressiva - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.
rimcure paed 60 mg/30 mg/150 mg dispergerbar tablett/tuggtablett
sandoz a/s - isoniazid; pyrazinamid; rifampicin - dispergerbar tablett/tuggtablett - 60 mg/30 mg/150 mg - aspartam hjälpämne; pyrazinamid 150 mg aktiv substans; isoniazid 30 mg aktiv substans; rifampicin 60 mg aktiv substans - pyrazinamid och isoniazid
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - pulmonell sjukdom, kronisk obstruktiv - läkemedel mot obstruktiv lungsjukdom, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.